TABLE OF CONTENTS

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.7        South and Central America Cardiometabolic Diseases market – By Country

2.           South and Central America Cardiometabolic Diseases Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           South and Central America Cardiometabolic Diseases Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.3         Expert Opinions

5.           South and Central America Cardiometabolic Diseases Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Increasing Prevalence of Cardiometabolic Diseases

5.1.2        Innovation in Cardiometabolic Diseases Therapeutics

5.2         Market Restraints

5.2.1        Underdiagnosis of CVDs in Low- and Middle-Income Countries (LMICs)

5.3         Market Opportunities

5.3.1        Technological Advancements in CMD Diagnosis

5.4         Future Trends

5.4.1        Personalized Treatment for CMDs

5.5         Impact Analysis

6.           South and Central America Cardiometabolic Diseases Market – Regional Analysis

6.1         South and Central America Cardiometabolic Diseases Market Revenue Forecast And Analysis

7.           South and Central America Cardiometabolic Diseases Market Analysis – By Type

7.1         Overview

7.2         Cardiometabolic Diseases Market Revenue Share, by Type (2020 and 2028)

7.3         Cardiovascular Disease (CVD)

7.3.1        Overview

7.3.2        Cardiovascular Disease (CVD): Cardiometabolic Diseases Market Revenue and Forecast to 2028 (US$ Mn)

7.4         Hypertension

7.4.1        Overview

7.4.2        Hypertension: Cardiometabolic Diseases Market Revenue and Forecast to 2028 (US$ Mn)

7.5         Type 2 Diabetes

7.5.1        Overview

7.5.2        Type 2 Diabetes: Cardiometabolic Diseases Market Revenue and Forecast to 2028 (US$ Mn)

7.6         Obesity

7.6.1        Overview

7.6.2        Obesity: Cardiometabolic Diseases Market Revenue and Forecast to 2028 (US$ Mn)

8.           South and Central America Cardiometabolic Diseases Market Analysis – By Treatment

8.1         Overview

8.2         Cardiometabolic Diseases Market Revenue Share, by Treatment (2020 and 2028)

8.3         ACE inhibitors

8.3.1        Overview

8.3.2        ACE: Cardiometabolic Diseases Inhibitors Market Revenue and Forecast to 2028 (US$ Mn)

8.4         Diuretics

8.4.1        Overview

8.4.2        Diuretics: Cardiometabolic Diseases Market Revenue and Forecast to 2028 (US$ Mn)

8.5         Glucophage

8.5.1        Overview

8.5.2        Glucophage: Cardiometabolic Diseases Market Revenue and Forecast to 2028 (US$ Mn)

8.6         Others

8.6.1        Overview

8.6.2        Others: Cardiometabolic Diseases Market Revenue and Forecast to 2028 (US$ Mn)

9.           South and Central America Cardiometabolic Diseases Market Analysis – By Dosage

9.1         Overview

9.2         Cardiometabolic Diseases Market Revenue Share, by Dosage (2020 and 2028)

9.3         Tablet

9.3.1        Overview

9.3.2        Tablet: Cardiometabolic Diseases Market Revenue and Forecast to 2028 (US$ Mn)

9.4         Injection

9.4.1        Overview

9.4.2        Injection: Cardiometabolic Diseases Market Revenue and Forecast to 2028 (US$ Mn)

10.        South and Central America Cardiometabolic Diseases Market Analysis – By Route of Administration

10.1      Overview

10.2      Cardiometabolic Diseases Market Share by Route of Administration 2021 & 2028 (%)

10.3      Oral

10.3.1     Overview

10.3.2     Oral Market Revenue and Forecast to 2028 (US$ Mn)

10.4      Intravenous

10.4.1     Overview

10.4.2     Intravenous Market Revenue and Forecast to 2028 (US$ Mn)

11.        South and Central America Cardiometabolic Diseases Market Analysis – By End User

11.1      Overview

11.2      Cardiometabolic Diseases Market Share by End Users 2020 & 2028 (%)

11.3      Clinic

11.3.1     Overview

11.3.2     Clinic Market Revenue and Forecast to 2028 (US$ Mn)

11.4      Hospital

11.4.1     Overview

11.4.2     Hospital Market Revenue and Forecast to 2028 (US$ Mn)

11.5      Homecare Settings

11.5.1     Overview

11.5.2     Homecare Settings Market Revenue and Forecast to 2028 (US$ Mn)

12.        South and Central America Cardiometabolic Diseases Market Analysis – By Distribution Channel

12.1      Overview

12.2      Cardiometabolic Diseases Market Share by Distribution Channel 2020 & 2028 (%)

12.3      Hospital Pharmacy

12.3.1     Overview

12.3.2     Hospital Pharmacy Market Revenue and Forecast to 2028 (US$ Mn)

12.4      Retail Pharmacy

12.4.1     Overview

12.4.2     Retail Pharmacy Market Revenue and Forecast to 2028 (US$ Mn)

12.5      Online Pharmacy

12.5.1     Overview

12.5.2     Online Pharmacy Market Revenue and Forecast to 2028 (US$ Mn)

13.        South and Central America Cardiometabolic Diseases Market – Geographic Analysis

13.1      South and Central America: Cardiometabolic Diseases Market

13.1.1     Overview

13.1.2     South and Central America: Cardiometabolic Diseases Market – Revenue and Forecast to 2028 (USD Million)

13.1.3     South and Central America: Cardiometabolic Diseases Market, by Type – Revenue and Forecast to 2028 (USD Million)

13.1.4     South and Central America: Cardiometabolic Diseases Market, by Treatment – Revenue and Forecast to 2028 (USD Million)

13.1.5     South and Central America: Cardiometabolic Diseases Market, by Dosage – Revenue and Forecast to 2028 (USD Million)

13.1.6     South and Central America: Cardiometabolic Diseases Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

13.1.7     South and Central America: Cardiometabolic Diseases Market, by End Users – Revenue and Forecast to 2028 (USD Million)

13.1.8     South and Central America: Cardiometabolic Diseases Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

13.1.9     South and Central America: Cardiometabolic Diseases Market, by Country, 2021 & 2028 (%)

13.1.9.1       Brazil: Cardiometabolic Diseases Market – Revenue and Forecast to 2028 (USD Million)

13.1.9.1.1       Brazil: Cardiometabolic Diseases Market – Revenue and Forecast to 2028 (USD Million)

13.1.10  Brazil: Cardiometabolic Diseases Market, by Type – Revenue and Forecast to 2028 (USD Million)

13.1.11  Brazil: Cardiometabolic Diseases Market, by Treatment – Revenue and Forecast to 2028 (USD Million)

13.1.12  Brazil: Cardiometabolic Diseases Market, by Dosage – Revenue and Forecast to 2028 (USD Million)

13.1.13  Brazil: Cardiometabolic Diseases Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

13.1.14  Brazil: Cardiometabolic Diseases Market, by End Users – Revenue and Forecast to 2028 (USD Million)

13.1.15  Brazil: Cardiometabolic Diseases Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

13.1.15.1    Argentina: Cardiometabolic Diseases Market – Revenue and Forecast to 2028 (USD Million)

13.1.15.1.1    Argentina: Cardiometabolic Diseases Market – Revenue and Forecast to 2028 (USD Million)

13.1.16  Argentina: Cardiometabolic Diseases Market, by Type – Revenue and Forecast to 2028 (USD Million)

13.1.17  Argentina: Cardiometabolic Diseases Market, by Treatment – Revenue and Forecast to 2028 (USD Million)

13.1.18  Argentina: Cardiometabolic Diseases Market, by Dosage – Revenue and Forecast to 2028 (USD Million)

13.1.19  Argentina: Cardiometabolic Diseases Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

13.1.20  Argentina: Cardiometabolic Diseases Market, by End Users – Revenue and Forecast to 2028 (USD Million)

13.1.21  Argentina: Cardiometabolic Diseases Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

13.1.21.1    Rest of South and Central America: Cardiometabolic Diseases Market – Revenue and Forecast to 2028 (USD Million)

13.1.21.1.1    Rest of South and Central America: Cardiometabolic Diseases Market – Revenue and Forecast to 2028 (USD Million)

13.1.22  Rest of South and Central America: Cardiometabolic Diseases Market, by Type – Revenue and Forecast to 2028 (USD Million)

13.1.23  Rest of South and Central America: Cardiometabolic Diseases Market, by Treatment – Revenue and Forecast to 2028 (USD Million)

13.1.24  Rest of South and Central America: Cardiometabolic Diseases Market, by Dosage – Revenue and Forecast to 2028 (USD Million)

13.1.25  Rest of South and Central America: Cardiometabolic Diseases Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

13.1.26  Rest of South and Central America: Cardiometabolic Diseases Market, by End Users – Revenue and Forecast to 2028 (USD Million)

13.1.27  Rest of South and Central America: Cardiometabolic Diseases Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

14.        Impact of COVID-19 Pandemic on South and Central America Cardiometabolic Diseases Market

14.1      South and Central America: Impact Assessment of COVID-19 Pandemic

15.        South and Central America Cardiometabolic Diseases Market – Industry Landscape

15.1      Overview

15.2      Growth Strategies in the Cardiometabolic Diseases Market (%)

15.3      Organic Developments

15.3.1     Overview

15.4      Inorganic Developments

15.4.1     Overview

16.        Company Profiles

16.1      Bayer AG

16.1.1     Key Facts

16.1.2     Business Description

16.1.3     Products and Services

16.1.4     Financial Overview

16.1.5     SWOT Analysis

16.1.6     Key Developments

16.2      Novartis AG

16.2.1     Key Facts

16.2.2     Business Description

16.2.3     Products and Services

16.2.4     Financial Overview

16.2.5     SWOT Analysis

16.2.6     Key Developments

16.3      Boehringer Ingelheim International GmbH

16.3.1     Key Facts

16.3.2     Business Description

16.3.3     Products and Services

16.3.4     Financial Overview

16.3.5     SWOT Analysis

16.3.6     Key Developments

16.4      Novo Nordisk A/S

16.4.1     Key Facts

16.4.2     Business Description

16.4.3     Products and Services

16.4.4     Financial Overview

16.4.5     SWOT Analysis

16.4.6     Key Developments

16.5      AstraZeneca

16.5.1     Key Facts

16.5.2     Business Description

16.5.3     Products and Services

16.5.4     Financial Overview

16.5.5     SWOT Analysis

16.5.6     Key Developments

16.6      Kowa Company, Ltd.

16.6.1     Key Facts

16.6.2     Business Description

16.6.3     Products and Services

16.6.4     Financial Overview

16.6.5     SWOT Analysis

16.6.6     Key Developments

17.        Appendix

17.1      About The Insight Partners

17.2      Glossary of Terms

LIST OF TABLES

Table 1.             South and Central America Cardiometabolic Diseases Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 2.             South and Central America Cardiometabolic Diseases Market, by Treatment – Revenue and Forecast to 2028 (USD Million)

Table 3.             South and Central America Cardiometabolic Diseases Market, by Dosage – Revenue and Forecast to 2028 (USD Million)

Table 4.             South and Central America Cardiometabolic Diseases Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 5.             South and Central America Cardiometabolic Diseases Market, by End Users – Revenue and Forecast to 2028 (USD Million)

Table 6.             South and Central America Cardiometabolic Diseases Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 7.             Brazil Cardiometabolic Diseases Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 8.             Brazil Cardiometabolic Diseases Market, by Treatment – Revenue and Forecast to 2028 (USD Million)

Table 9.             Brazil Cardiometabolic Diseases Market, by Dosage – Revenue and Forecast to 2028 (USD Million)

Table 10.          Brazil Cardiometabolic Diseases Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 11.          Brazil Cardiometabolic Diseases Market, by End Users – Revenue and Forecast to 2028 (USD Million)

Table 12.          Brazil Cardiometabolic Diseases Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 13.          Argentina Cardiometabolic Diseases Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 14.          Argentina Cardiometabolic Diseases Market, by Treatment – Revenue and Forecast to 2028 (USD Million)

Table 15.          Argentina Cardiometabolic Diseases Market, by Dosage – Revenue and Forecast to 2028 (USD Million)

Table 16.          Argentina Cardiometabolic Diseases Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 17.          Argentina Cardiometabolic Diseases Market, by End Users – Revenue and Forecast to 2028 (USD Million)

Table 18.          Argentina Cardiometabolic Diseases Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 19.          Rest of South and Central America Cardiometabolic Diseases Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 20.          Rest of South and Central America Cardiometabolic Diseases Market, by Treatment – Revenue and Forecast to 2028 (USD Million)

Table 21.          Rest of South and Central America Cardiometabolic Diseases Market, by Dosage – Revenue and Forecast to 2028 (USD Million)

Table 22.          Rest of South and Central America Cardiometabolic Diseases Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 23.          Rest of South and Central America Cardiometabolic Diseases Market, by End Users – Revenue and Forecast to 2028 (USD Million)

Table 24.          Rest of South and Central America Cardiometabolic Diseases Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 25.          Organic Developments in the Cardiometabolic Diseases Market

Table 26.          Inorganic Developments in the Cardiometabolic Diseases Market

Table 27.          Glossary of Terms, South and Central America Cardiometabolic Diseases Market

LIST OF FIGURES

Figure 1.           South and Central America Cardiometabolic Diseases Market Segmentation

Figure 2.           South and Central America Cardiometabolic Diseases Market Overview

Figure 3.           Cardiovascular Disease (CVD) Segment Held Largest Share of Type of South and Central America Cardiometabolic Diseases Market

Figure 4.           South and Central America Cardiometabolic Diseases Market – Leading Country Markets (US$ Million)

Figure 5.           South and Central America Cardiometabolic Diseases Market, Industry Landscape

Figure 6.           South and Central America PEST Analysis

Figure 7.           South and Central America Cardiometabolic Diseases Market Impact Analysis of Drivers and Restraints

Figure 8.           South and Central America Cardiometabolic Diseases Market – Revenue Forecast And Analysis – 2020- 2028

Figure 9.           Cardiometabolic Diseases Market Revenue Share, by Type (2020 and 2028)

Figure 10.        Cardiovascular Disease (CVD): Cardiometabolic Diseases Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 11.        Hypertension: Cardiometabolic Diseases Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 12.        Type 2 Diabetes: Cardiometabolic Diseases Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 13.        Obesity: Cardiometabolic Diseases Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 14.        Cardiometabolic Diseases Market Revenue Share, by Treatment (2020 and 2028)

Figure 15.        ACE inhibitors: Cardiometabolic Diseases Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 16.        Diuretics: Cardiometabolic Diseases Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 17.        Glucophage: Cardiometabolic Diseases Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 18.        Others: Cardiometabolic Diseases Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 19.        Cardiometabolic Diseases Market Revenue Share, by Dosage (2020 and 2028)

Figure 20.        Tablet: Cardiometabolic Diseases Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 21.        Injection: Cardiometabolic Diseases Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 22.        Cardiometabolic Diseases Market Share by Route of Administration 2021 & 2028 (%)

Figure 23.        Oral Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 24.        Intravenous Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 25.        Cardiometabolic Diseases Market Share by End Users 2020 & 2028 (%)

Figure 26.        Clinic Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 27.        Hospital Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 28.        Homecare Settings Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 29.        Cardiometabolic Diseases Market Share by Distribution Channel 2020 & 2028 (%)

Figure 30.        Hospital Pharmacy Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 31.        Retail Pharmacy Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 32.        Online Pharmacy Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 33.        South and Central America: Cardiometabolic Diseases Market, by Key Country – Revenue (2021) (USD Million)

Figure 34.        South and Central America Cardiometabolic Diseases Market Revenue and Forecast to 2028 (USD Million)

Figure 35.        South and Central America: Cardiometabolic Diseases Market, by Country, 2021 & 2028 (%)

Figure 36.        Brazil: Cardiometabolic Diseases Market – Revenue and Forecast to 2028 (USD Million)

Figure 37.        Argentina: Cardiometabolic Diseases Market – Revenue and Forecast to 2028 (USD Million)

Figure 38.        Rest of South and Central America: Cardiometabolic Diseases Market – Revenue and Forecast to 2028 (USD Million)

Figure 39.        Impact of COVID-19 Pandemic on South and Central America Cardiometabolic Diseases Market

Figure 40.        Growth Strategies in the Cardiometabolic Diseases Market (%)